Head and Neck Neoplasms  >>  Inlyta (axitinib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Inlyta (axitinib) / Pfizer
NCT00176748: Treatment for Patients With Metastatic Thyroid Cancer

Completed
2
3
US
AG 6013736
University of Michigan Rogel Cancer Center, Pfizer
Thyroid Cancer
08/06
06/09
NCT00094055: Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer

Completed
2
60
US
AG013736
Pfizer
Thyroid Neoplasms
01/09
01/09
NCT00389441: Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer

Completed
2
52
US, Canada, Europe, RoW
AG-013736
Pfizer
Thyroid Neoplasms
09/12
09/12

Download Options